Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Wonjun Son"'
Autor:
Eunjung Lee, Hyejin Chung, Yangsoon Lee, Young Bong Park, Eun-Jung Lee, Hyunmo Koo, Mikyeong Ju, Ju Young Park, Sujin Ahn, Junhwan Kim, Kyeongsu Park, Wonjun Son, Jaehyun Eom, Hanbyul Lee, Jaeho Jung, Jonghwa Won, Se-Woong Oh
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a804064fdfee4a0451640666c8e75114
https://doi.org/10.1136/jitc-2022-sitc2022.1058
https://doi.org/10.1136/jitc-2022-sitc2022.1058
Publikováno v:
Biophys J
The totally asymmetric simple exclusion process (TASEP), which describes the stochastic dynamics of interacting particles on a lattice, has been actively studied over the past several decades and applied to model important biological transport proces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6be843413425b4bd9b966dd600266ab6
https://doi.org/10.1016/j.bpj.2021.02.004
https://doi.org/10.1016/j.bpj.2021.02.004
Autor:
Yangsoon Lee, Kyeong-Su Park, Wonjun Son, Sora Kim, Hyunseong Youn, Jiseon Yoo, Hanbyul Lee, Jonghwa Won
Publikováno v:
Cancer Research. 83:2941-2941
ROR1, a member of the ROR (Receptor Tyrosine Kinase-Like Orphan Receptor)-family, is overexpressed in the process of embryo and fetal development, and controls cell polarity, cell migration and neurite growth. The expression is gradually reduced as d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31cd938e1c0a18fcb551c6b0b52833e8
https://doi.org/10.1158/1538-7445.am2023-2941
https://doi.org/10.1158/1538-7445.am2023-2941
Autor:
Eunjung Lee, Hyejin Chung, Yangsoon Lee, Eun-jung Lee, Young Bong Park, Ju Young Park, Sujin Ahn, Junhwan Kim, Kyoung Kyu Ahn, Kyeongsu Park, Wonjun Son, Donghoon Yeom, Jaeho Jung, Jonghwa Won, Se-Woong Oh
Publikováno v:
Cancer Research. 82:1139-1139
Although HER2-targeted therapies such as Herceptin® (trastuzumab) have dramatically improved outcomes for solid cancer patients with HER2 overexpression, it remains a challenge to cure the HER2 positive cancer patients with resistance to current HER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58d7fedf98ed248256d8576d91eaab40
https://doi.org/10.1158/1538-7445.am2022-1139
https://doi.org/10.1158/1538-7445.am2022-1139
Autor:
Seung-Woo Lee, Shinai Lee, Wonjun Son, Eunyoung Park, Yunji Park, Park Kyeongsu, Sora Kim, Ji-Hae Kim, Yeon-Woo Kang, Yangsoon Lee, Jonghwa Won, Han Wook Park, Yong-Gyu Son, Jung Uijung, Young-Min Kim, Dain Moon, Gihoon You, Hyekang Kim, Eom Jaehyun, Chung Hyejin, Jaeho Jung
Publikováno v:
Science Advances. 7
Cancer immunotherapy with 4-1BB agonists has limited further clinical development because of dose-limiting toxicity. Here, we developed a bispecific antibody (bsAb; B7-H3×4-1BB), targeting human B7-H3 (hB7-H3) and mouse or human 4-1BB, to restrict t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb09c064bc95e7a137574a83469293c3
https://doi.org/10.1126/sciadv.aax3160
https://doi.org/10.1126/sciadv.aax3160
Autor:
Gihoon, You, Yangsoon, Lee, Yeon-Woo, Kang, Han Wook, Park, Kyeongsu, Park, Hyekang, Kim, Young-Min, Kim, Sora, Kim, Ji-Hae, Kim, Dain, Moon, Hyejin, Chung, Wonjun, Son, Ui-Jung, Jung, Eunyoung, Park, Shinai, Lee, Yong-Gyu, Son, Jaehyun, Eom, Jonghwa, Won, Yunji, Park, Jaeho, Jung, Seung-Woo, Lee
Publikováno v:
Science Advances
Tumor-targeted T cell costimulatory antibody augments antitumor immunity by enhancing tumor-killing T cells within the tumor.
Cancer immunotherapy with 4-1BB agonists has limited further clinical development because of dose-limiting toxicity. He
Cancer immunotherapy with 4-1BB agonists has limited further clinical development because of dose-limiting toxicity. He
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2aabd32c75c85658a5b999d46b4b430c
https://pubmed.ncbi.nlm.nih.gov/33523913
https://pubmed.ncbi.nlm.nih.gov/33523913
Autor:
Dae Won Kim, Sung Byungje, Yangsoon Lee, KyeongBae Kim, Su Jin Ahn, Wonjun Son, Yeom Donghoon, J.K. Lee, Chung Hyejin, Weon-Kyoo You, Ju Young Park, Eun Jung Kim, Young Bong Park, Song Daehae, Mikyeong Ju, Eom Jaehyun, Ahn Jinhyung, Jaeho Jung, Moo Young Song, Jung Uijung, Jong Gyun Kim, Jun Hwan Kim, Eunjung Lee, Park Kyeongsu, Se-Woong Oh, Min Hyeok Jee, Kyoung Kyu Ahn, Byung Hyun Choi
Publikováno v:
Cancer Research. 80:6524-6524
4-1BB (TNFSF9, CD137) is a member of the tumor necrosis factor receptor superfamily that functions as a potent costimulator to immune cells, especially T-cell. Although current 4-1BB-targeted strong agonistic antibody exhibit a considerable anti-tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::641a145082ac2aff838bf92950391a5a
https://doi.org/10.1158/1538-7445.am2020-6524
https://doi.org/10.1158/1538-7445.am2020-6524
Autor:
Byeong-Ho Jeong, Beomsu Shin, Jung Seop Eom, Hongseok Yoo, Wonjun Song, Sangbin Han, Kyung Jong Lee, Kyeongman Jeon, Sang-Won Um, Won-Jung Koh, Gee Young Suh, Man Pyo Chung, Hojoong Kim, O Jung Kwon, Sookyoung Woo, Hye Yun Park
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e113656 (2014)
Patient- and procedure-related factors associated with postoperative pulmonary complications (PPCs) have changed over the last decade. Therefore, we sought to identify independent risk factors of PPCs and to develop a clinically applicable scoring sy
Externí odkaz:
https://doaj.org/article/743703f8066e4110a909b0b07aa25a25
Autor:
Gihoon You1, Yangsoon Lee2, Yeon-Woo Kang1, Han Wook Park1, Kyeongsu Park2, Hyekang Kim1, Young-Min Kim1, Sora Kim1, Ji-Hae Kim3, Dain Moon1, Hyejin Chung2, Wonjun Son2, Ui-jung Jung2, Eunyoung Park2, Shinai Lee2, Yong-Gyu Son2, Jaehyun Eom2, Jonghwa Won2, Yunji Park1, Jaeho Jung2 jaeho.jung@ablbio.com
Publikováno v:
Science Advances. 1/13/2021, Vol. 7 Issue 3, p1-15. 15p.